Topic

Articles

The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.  

Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation

The case for migrating from a paper-based quality management system to a digital platform is presented.


Viewpoint: Digitizing Processes to Align with GMP Requirements 

Editor of Pharmaceutical Technology Europe

European pharma companies may have a vested interest in the outcome of the US elections.

The Elephant (or Donkey) in the Room

AstraZeneca has potentially taken poll position in the race to develop a novel coronavirus vaccine, but will AZD1222 be ready in 2020?

Leader of the Pack?

Tony Cordrey is vice‑president of European Strategic Operations, Accord Healthcare.

COVID-19 has brought to light the issues of European manufacturing capabilities, leading industry to question whether it is now time to reinvest in domestic medicines supply.

Reinvesting in European Manufacturing

COVID-19’s impact on the global economy is dealing a blow to merger and acquisition activity in the biopharma industry.

Dealing a Blow to Biopharma

COVID-19 vaccines are being developed rapidly, giving rise to a reinvigoration of the sector.

Unprecedented Times in Vaccines

As Brexit talks intensify, bio/pharma companies from both the UK and EU need to consider and aim to prepare for all scenarios.

No Business, Like Brexit Business

Pharma’s reputation is being boosted in light of the current COVID-19 pandemic efforts.

A Little More Respect

Dr. Reddy Gottipolu is SVP Healthcare at One Network Enterprises, provider of an AI-enabled business network platform that enables all trading partners to manage, optimize and automate complex business processes in real time.

A network-based supply chain approach has the potential to improve resilience and performance.

Viewpoints